VOL. XCIV, NO. 247

★ FINANCIAL TOOLS & SERVICES DIRECTORY ★

PRICE: 5 CENTS

Monday, October 6, 2025

Head-to-head

InvestorGain vs TradingView comparison

Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.

Quick takeaways

InvestorGain adds IPO, Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, and Blogs coverage that TradingView skips.

TradingView includes Screeners, ETF Screeners, Stock Ideas, Data Visualizations, Options & Derivatives, Portfolio, Watchlist, Backtesting, Paper Trading, Advanced Order Types, Smart/Direct Routing, News, Alerts, Order Book / Level II, Dividends, Splits, Financials, ETF Overview, and Forums categories that InvestorGain omits.

InvestorGain highlights: Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)..

TradingView is known for: Flexible charting with up to 16 charts per layout, synchronized by symbol and timeframe., Over 400 built-in indicators, 100,000+ community scripts, and 110+ drawing tools., and Server-side alerts with 13 conditions, drawing-tool triggers, and webhook integrations..

InvestorGain logo

InvestorGain

investorgain.com

India‑focused IPO & primary‑markets portal with live IPO subscription tracking, Grey Market Premium (GMP) dashboards, anchor investor allocations, and new‑issue calendars (NCDs, SGBs, rights). Provides broker reviews/comparisons and free brokerage calculators. GMP is expressly noted as based on market perception/public sources; the site states it does not work with GMP operators and content is for education/news. The business is ad/affiliate‑supported.

Platforms

Web
Mobile

Pricing

Free

Quick highlights

  • Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
  • Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
  • IPO anchor investor allocation reports by year (mainboard & SME).
  • IPO performance history and GMP‑vs‑actual listing performance trackers.
  • Rights issues dashboard (record date, entitlement, pricing, timelines).

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
TradingView logo

TradingView

tradingview.com

Editor’s pick Hands-on review

A global, multi-asset charting and trading platform with advanced analytics, strategy backtesting, and broker connectivity. Features include Pine Script® v6 for custom indicators, server-side alerts, options chains with strategy builder, and multi-asset screeners. Real-time data feeds are sold as add-ons, with availability and pricing varying by exchange and region.

Platforms

Web
Mobile
Desktop

Pricing

Free
Subscription

Quick highlights

  • Flexible charting with up to 16 charts per layout, synchronized by symbol and timeframe.
  • Over 400 built-in indicators, 100,000+ community scripts, and 110+ drawing tools.
  • Server-side alerts with 13 conditions, drawing-tool triggers, and webhook integrations.
  • Equity, ETF, forex, and crypto screeners with auto-refresh and export options.
  • Pine Script® v6 for creating custom indicators and strategies.

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
Overlap

Shared focus areas

2 overlaps

Mutual strengths include Calendar, and Education.

Where they differ

InvestorGain

Distinct strengths include:

  • Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
  • Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
  • IPO anchor investor allocation reports by year (mainboard & SME).
  • IPO performance history and GMP‑vs‑actual listing performance trackers.

TradingView

Distinct strengths include:

  • Flexible charting with up to 16 charts per layout, synchronized by symbol and timeframe.
  • Over 400 built-in indicators, 100,000+ community scripts, and 110+ drawing tools.
  • Server-side alerts with 13 conditions, drawing-tool triggers, and webhook integrations.
  • Equity, ETF, forex, and crypto screeners with auto-refresh and export options.

Feature-by-feature breakdown

AttributeInvestorGainTradingView
Categories

Which research workflows each platform targets

Shared: Calendar, Education

Unique: IPO, Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, Blogs

Shared: Calendar, Education

Unique: Screeners, ETF Screeners, Stock Ideas, Data Visualizations, Options & Derivatives, Portfolio, Watchlist, Backtesting, Paper Trading, Advanced Order Types, Smart/Direct Routing, News, Alerts, Order Book / Level II, Dividends, Splits, Financials, ETF Overview, Forums

Asset types

Supported asset classes and universes

Stocks, Bonds

Stocks, ETFs, Options, Futures, Bonds, Currencies, Commodities, Cryptos

Experience levels

Who each product is built for

Beginner, Intermediate, Advanced

Beginner, Intermediate, Advanced

Platforms

Where you can access the product

Web, Mobile

Web, Mobile, Desktop

Pricing

High-level pricing models

Free

Free, Subscription

Key features

Core capabilities called out by each vendor

Unique

  • Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
  • Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
  • IPO anchor investor allocation reports by year (mainboard & SME).
  • IPO performance history and GMP‑vs‑actual listing performance trackers.
  • Rights issues dashboard (record date, entitlement, pricing, timelines).
  • NCD (Non‑Convertible Debenture) issues tracker (coupon, rating, tenor, series).

Unique

  • Flexible charting with up to 16 charts per layout, synchronized by symbol and timeframe.
  • Over 400 built-in indicators, 100,000+ community scripts, and 110+ drawing tools.
  • Server-side alerts with 13 conditions, drawing-tool triggers, and webhook integrations.
  • Equity, ETF, forex, and crypto screeners with auto-refresh and export options.
  • Pine Script® v6 for creating custom indicators and strategies.
  • Strategy Tester with robust backtesting and Bar Replay for historical simulation.
Tested

Verified by hands-on testing inside Find My Moat

Not yet

Yes

Editor pick

Featured inside curated shortlists

Standard listing

Highlighted

Frequently Asked Questions

Which workflows do InvestorGain and TradingView both support?

Both platforms cover Calendar, and Education workflows, so you can research those use cases in either tool before digging into the feature differences below.

Do InvestorGain and TradingView require subscriptions?

Both InvestorGain and TradingView keep freemium access with optional paid upgrades, so you can trial each platform before committing.

How can you access InvestorGain and TradingView?

Both InvestorGain and TradingView support web and mobile access, making it easy to keep tabs on research away from the desk.

What unique strengths set the two platforms apart?

InvestorGain differentiates itself with Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)., whereas TradingView stands out for Flexible charting with up to 16 charts per layout, synchronized by symbol and timeframe., Over 400 built-in indicators, 100,000+ community scripts, and 110+ drawing tools., and Server-side alerts with 13 conditions, drawing-tool triggers, and webhook integrations..

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.